Care Package for Preventing Pressure Ulcers in ICU Patients
NCT ID: NCT06509399
Last Updated: 2024-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2023-05-15
2023-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Pressure Ulcer Care Package on the Risk of Pressure Ulcer Development
NCT06330506
Prevention to Pressure Injury With Care Bundle
NCT05541198
Pressure Injury Training With a Blended Approach Learning Approach on Care Behaviors of Intensive Care Nurses
NCT05762341
The Effect of Care Bundle in Preventing Pressure Ulcers Caused by Medical Devices in the Pediatric Intensive Care Unit
NCT05406986
The Effect of Pressure Wound Care Package on the Development of Operating Room Pressure Wound in Orthopedic Surgery
NCT05852236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRESSURE ULCERS PREVENTION CARE PACKAGE IN INTENSİVE CARE UNIT
This experimental study was carried out in the anesthesia and reanimation intensive care unit of Düzce Atatürk State Hospital. The part with patients was completed with a total of 72 patients, 36 in the control group and 36 in the application group. The occurrence rate of PI was compared between the control group and the application group.
care package
Before the patients in the application group started to be observed, the nurses working in the clinic were trained about the risk assessment, skin assessment, incontinence management, nutrition assessment, positioning, support surfaces and injuries caused by the devices in the BP content to be used in the prevention of IU. After the trainings given to the nurses were completed, care was given to the patients in the practice group in accordance with BP. In addition, patient information was collected from patient information files, nurse observation forms and hospital automation system. In the evaluation step, full compliance with the 7 compliance steps specified in the BP was sought. If any one of these parameters was incomplete, the others were considered as incomplete.
The patients in the control group were followed up for 30 days until the determined number of patients was reached and their data were collected.
NURSES' LEVEL OF KNOWLEDGE ABOUT THE CARE PACKAGE
In the section about nurses, no sample was selected and all 50 nurses working in intensive care were included in the study. Nurses' knowledge and attitudes about PI before and after the training were compared.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
care package
Before the patients in the application group started to be observed, the nurses working in the clinic were trained about the risk assessment, skin assessment, incontinence management, nutrition assessment, positioning, support surfaces and injuries caused by the devices in the BP content to be used in the prevention of IU. After the trainings given to the nurses were completed, care was given to the patients in the practice group in accordance with BP. In addition, patient information was collected from patient information files, nurse observation forms and hospital automation system. In the evaluation step, full compliance with the 7 compliance steps specified in the BP was sought. If any one of these parameters was incomplete, the others were considered as incomplete.
The patients in the control group were followed up for 30 days until the determined number of patients was reached and their data were collected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No development of pressure ulcers in any part of the body,
* Patients expected to stay in the clinic for at least 72 hours or more
* patients with a braden score below 15 points
* Obtaining written consent from the first-degree relatives of patients whose written consent is obtained, patients who are unconscious and unable to give consent
Exclusion Criteria
* BY in any part of the body,
* BBYRDS score more than 15
* Failure to give written consent by himself/herself or his/her 1st degree relative
* Exitus, discharge, change of department and the patient's wish to leave the study before completing the number of days determined during the data collection phase
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ganime Esra Soysal
Assistant Professor of Surgical Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abant Izzet Baysal University Faculty of Health Science
Bolu, Merkez, Turkey (Türkiye)
Bolu Abant İzzet Baysal Üniversitesi/Sağlık Bilimleri Fakültesi
Bolu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBF-HMS-GES-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.